Application of a modified sequential organ failure assessment score to critically ill patients

Detalhes bibliográficos
Autor(a) principal: Ñamendys-Silva,S.A.
Data de Publicação: 2013
Outros Autores: Silva-Medina,M.A., Vásquez-Barahona,G.M., Baltazar-Torres,J.A., Rivero-Sigarroa,E., Fonseca-Lazcano,J.A., Domínguez-Cherit,G.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000200186
Resumo: The purpose of the present study was to explore the usefulness of the Mexican sequential organ failure assessment (MEXSOFA) score for assessing the risk of mortality for critically ill patients in the ICU. A total of 232 consecutive patients admitted to an ICU were included in the study. The MEXSOFA was calculated using the original SOFA scoring system with two modifications: the PaO2/FiO2 ratio was replaced with the SpO2/FiO2 ratio, and the evaluation of neurologic dysfunction was excluded. The ICU mortality rate was 20.2%. Patients with an initial MEXSOFA score of 9 points or less calculated during the first 24 h after admission to the ICU had a mortality rate of 14.8%, while those with an initial MEXSOFA score of 10 points or more had a mortality rate of 40%. The MEXSOFA score at 48 h was also associated with mortality: patients with a score of 9 points or less had a mortality rate of 14.1%, while those with a score of 10 points or more had a mortality rate of 50%. In a multivariate analysis, only the MEXSOFA score at 48 h was an independent predictor for in-ICU death with an OR = 1.35 (95%CI = 1.14-1.59, P < 0.001). The SOFA and MEXSOFA scores calculated 24 h after admission to the ICU demonstrated a good level of discrimination for predicting the in-ICU mortality risk in critically ill patients. The MEXSOFA score at 48 h was an independent predictor of death; with each 1-point increase, the odds of death increased by 35%.
id ABDC-1_dfef8b026d1ba9920fdda641248dba2f
oai_identifier_str oai:scielo:S0100-879X2013000200186
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Application of a modified sequential organ failure assessment score to critically ill patientsSequential organ failure assessment scoreOrgan dysfunctionCritically ill patientsMortalityIntensive care unit survivalMEXSOFAThe purpose of the present study was to explore the usefulness of the Mexican sequential organ failure assessment (MEXSOFA) score for assessing the risk of mortality for critically ill patients in the ICU. A total of 232 consecutive patients admitted to an ICU were included in the study. The MEXSOFA was calculated using the original SOFA scoring system with two modifications: the PaO2/FiO2 ratio was replaced with the SpO2/FiO2 ratio, and the evaluation of neurologic dysfunction was excluded. The ICU mortality rate was 20.2%. Patients with an initial MEXSOFA score of 9 points or less calculated during the first 24 h after admission to the ICU had a mortality rate of 14.8%, while those with an initial MEXSOFA score of 10 points or more had a mortality rate of 40%. The MEXSOFA score at 48 h was also associated with mortality: patients with a score of 9 points or less had a mortality rate of 14.1%, while those with a score of 10 points or more had a mortality rate of 50%. In a multivariate analysis, only the MEXSOFA score at 48 h was an independent predictor for in-ICU death with an OR = 1.35 (95%CI = 1.14-1.59, P < 0.001). The SOFA and MEXSOFA scores calculated 24 h after admission to the ICU demonstrated a good level of discrimination for predicting the in-ICU mortality risk in critically ill patients. The MEXSOFA score at 48 h was an independent predictor of death; with each 1-point increase, the odds of death increased by 35%.Associação Brasileira de Divulgação Científica2013-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000200186Brazilian Journal of Medical and Biological Research v.46 n.2 2013reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/1414-431X20122308info:eu-repo/semantics/openAccessÑamendys-Silva,S.A.Silva-Medina,M.A.Vásquez-Barahona,G.M.Baltazar-Torres,J.A.Rivero-Sigarroa,E.Fonseca-Lazcano,J.A.Domínguez-Cherit,G.eng2015-10-08T00:00:00Zoai:scielo:S0100-879X2013000200186Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2015-10-08T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Application of a modified sequential organ failure assessment score to critically ill patients
title Application of a modified sequential organ failure assessment score to critically ill patients
spellingShingle Application of a modified sequential organ failure assessment score to critically ill patients
Ñamendys-Silva,S.A.
Sequential organ failure assessment score
Organ dysfunction
Critically ill patients
Mortality
Intensive care unit survival
MEXSOFA
title_short Application of a modified sequential organ failure assessment score to critically ill patients
title_full Application of a modified sequential organ failure assessment score to critically ill patients
title_fullStr Application of a modified sequential organ failure assessment score to critically ill patients
title_full_unstemmed Application of a modified sequential organ failure assessment score to critically ill patients
title_sort Application of a modified sequential organ failure assessment score to critically ill patients
author Ñamendys-Silva,S.A.
author_facet Ñamendys-Silva,S.A.
Silva-Medina,M.A.
Vásquez-Barahona,G.M.
Baltazar-Torres,J.A.
Rivero-Sigarroa,E.
Fonseca-Lazcano,J.A.
Domínguez-Cherit,G.
author_role author
author2 Silva-Medina,M.A.
Vásquez-Barahona,G.M.
Baltazar-Torres,J.A.
Rivero-Sigarroa,E.
Fonseca-Lazcano,J.A.
Domínguez-Cherit,G.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Ñamendys-Silva,S.A.
Silva-Medina,M.A.
Vásquez-Barahona,G.M.
Baltazar-Torres,J.A.
Rivero-Sigarroa,E.
Fonseca-Lazcano,J.A.
Domínguez-Cherit,G.
dc.subject.por.fl_str_mv Sequential organ failure assessment score
Organ dysfunction
Critically ill patients
Mortality
Intensive care unit survival
MEXSOFA
topic Sequential organ failure assessment score
Organ dysfunction
Critically ill patients
Mortality
Intensive care unit survival
MEXSOFA
description The purpose of the present study was to explore the usefulness of the Mexican sequential organ failure assessment (MEXSOFA) score for assessing the risk of mortality for critically ill patients in the ICU. A total of 232 consecutive patients admitted to an ICU were included in the study. The MEXSOFA was calculated using the original SOFA scoring system with two modifications: the PaO2/FiO2 ratio was replaced with the SpO2/FiO2 ratio, and the evaluation of neurologic dysfunction was excluded. The ICU mortality rate was 20.2%. Patients with an initial MEXSOFA score of 9 points or less calculated during the first 24 h after admission to the ICU had a mortality rate of 14.8%, while those with an initial MEXSOFA score of 10 points or more had a mortality rate of 40%. The MEXSOFA score at 48 h was also associated with mortality: patients with a score of 9 points or less had a mortality rate of 14.1%, while those with a score of 10 points or more had a mortality rate of 50%. In a multivariate analysis, only the MEXSOFA score at 48 h was an independent predictor for in-ICU death with an OR = 1.35 (95%CI = 1.14-1.59, P < 0.001). The SOFA and MEXSOFA scores calculated 24 h after admission to the ICU demonstrated a good level of discrimination for predicting the in-ICU mortality risk in critically ill patients. The MEXSOFA score at 48 h was an independent predictor of death; with each 1-point increase, the odds of death increased by 35%.
publishDate 2013
dc.date.none.fl_str_mv 2013-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000200186
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000200186
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1414-431X20122308
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.46 n.2 2013
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302942019584000